He's a 78-year-old man. We diagnosed him with COPD last episode. He was hospitalized with a COPD exacerbation. You're seeing him for the first time in your pulmonary clinic to talk about medications.

Over-the-counter (OTC) inhalers are not approved for treating chronic obstructive pulmonary disease (COPD). Aside from the fact that they are ineffective for COPD, these inhalers can pose risks ...

When measuring inhaled COPD medication adherence through ARMS, 38.3% of veterans reached adherence, and the same was true when using ReComp scores, with 38.3% of veterans deemed adherent.

This particular study assessed over a 6-month period that if you could deliver all 3 medications in a single device compared with multiple devices, more [patients] had a positive response in terms ...

Due to misleading claims in a sales aid for Breztri Aerosphere, a triple inhaled therapy for COPD, the FDA has issued a warning letter to its manufacturer, AstraZeneca. Read more.

When life-saving inhalers sell in Europe at 1.5% to about 8% of their list price in the U.S., they’re bound to attract scrutiny, especially in a time when inequities in prescription drug prices are ...